Real world, multicentre patterns of treatment and survival in metastatic renal cell carcinoma with the UK Renal Oncology Collaborative (UK ROC): Is it time to look favourably on first‐line immunotherapy containing combinations in all IMDC groups?

Autor: McGrane, John¹ (AUTHOR) john.mcgrane@nhs.net, Frazer, Ricky² (AUTHOR), Challapalli, Amarnath³ (AUTHOR), Ratnayake, Gihan⁴ (AUTHOR), Boh, Zhaung⁵ (AUTHOR), Clayton, Alison⁶ (AUTHOR), Chau, Caroline⁷ (AUTHOR), Sharma, Anand⁸ (AUTHOR), Elgendy, Manal⁹ (AUTHOR), Charnley, Natalie¹⁰ (AUTHOR), Mohamed, Wael¹¹ (AUTHOR), Kingdon, Sarah¹² (AUTHOR), Protheroe, Andrew¹³ (AUTHOR), Lydon, Anna¹⁴ (AUTHOR), Halstead, Anna¹⁵ (AUTHOR), Ford, Vicky¹⁶ (AUTHOR), Muazzam, Iqtedar¹⁷ (AUTHOR), Lee, Dawn¹⁸ (AUTHOR), Melendez‐Torres, G. J.¹⁸ (AUTHOR), Bahl, Amit³ (AUTHOR)

Publikováno v: Cancer Medicine. Jun2024, Vol. 13 Issue 12, p1-12. 12p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Obesity and visceral fat: Survival impact in high-grade endometrial cancer

Autor: Donkers, Hannah, Fasmer, Kristine E., Mcgrane, John, Pijnenborg, Johanna M.A., Bekkers, Ruud, Haldorsen, Ingfrid S., Galaal, Khadra

Publikováno v: In European Journal of Obstetrics & Gynecology and Reproductive Biology January 2021 256:425-432

A UK real-world observational study of avelumab + axitinib (A + Ax) in advanced renal cell carcinoma (aRCC): Outcomes at 36 months post treatment initiation.

Autor: Nathan, Paul D., Charnley, Natalie, Frazer, Ricky, McGrane, John, Muazzam, Iqtedar, Pillai, Manon, Rudman, Sarah, Sharma, Anand, Stevenson, Robert, Venugopal, Balaji, Hickey, Joseph David, Ritchie, Aimi Rose, Liu, Kin

Publikováno v: Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p386-386, 140p

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.